Biofrontera announced the appointment of George Jones as chief commercial officer, starting August 25. In this role, Jones will oversee the company’s commercial functions, including sales, marketing, and market access. He will report directly to CEO Hermann Luebbert.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BFRI:
- Biofrontera, Inc. (BFRI) Q2 Earnings Cheat Sheet
- Biofrontera Inc. files to sell 13.6M shares of common stock for holders
- Biofrontera Finalizes Acquisition of U.S. Ameluz Rights
- Biofrontera Restructures U.S. Rights with $11M Investment
- Biofrontera Inc. price target raised to $10 from $8 at Roth Capital